| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/01/1997 | CN1036006C Antibiotic compound carbapenem |
| 10/01/1997 | CN1036005C Preparation of parmaceutical composition containing derivative of 7-pyrrolidinyl-3-chinolon and-naphthyridon carboxylic acid |
| 10/01/1997 | CN1036003C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives |
| 10/01/1997 | CN1036002C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives |
| 10/01/1997 | CN1035997C Ligands and metal complexes thereof |
| 10/01/1997 | CN1035996C Stilbene derivatives and carcinostatics |
| 10/01/1997 | CN1035986C Process for preparing composition of sustained release bolus |
| 10/01/1997 | CA2201413A1 Oral composition of fumagillol derivative |
| 09/30/1997 | US5672757 Antitumor agents |
| 09/30/1997 | US5672711 Condensation, acylation; forming cefotaxime |
| 09/30/1997 | US5672709 Heterocyclic compounds and their preparation and use |
| 09/30/1997 | US5672707 9-aminoacridine derivatives possessing psychotropic, antiamnestic and lipid-regulative activity |
| 09/30/1997 | US5672705 Antiischemic agents treating nervous system disorders, huntington' disease, alzheimer's disease, parkinson's disease |
| 09/30/1997 | US5672700 Antibiotics |
| 09/30/1997 | US5672698 Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine |
| 09/30/1997 | US5672697 Form oligonucleotides stable to nuclease degradation |
| 09/30/1997 | US5672695 Modified ribozymes |
| 09/30/1997 | US5672693 Lipopolysaccharides a cell membrane extract from gramnegative bacteria used as b cell activators |
| 09/30/1997 | US5672625 Sulfonic stilbene derivatives in the treatment of viral diseases |
| 09/30/1997 | US5672624 Endoperoxides useful as antiparasitic agents |
| 09/30/1997 | US5672622 Phosphodiesterase inhibitor; rolipram |
| 09/30/1997 | US5672620 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/30/1997 | US5672618 Protein kinase C inhibitors |
| 09/30/1997 | US5672616 Fungicide |
| 09/30/1997 | US5672615 Arylsulfonamido-substituted hydrodxamic acids |
| 09/30/1997 | US5672613 2-(4-methoxyphenoxy)-3-pyridineamine, its pharmaceutical compositions and therapeutic use |
| 09/30/1997 | US5672612 Amorphous paroxetine composition |
| 09/30/1997 | US5672611 Antitumor agents, farnesyl protein transferase enzyme inhibitors |
| 09/30/1997 | US5672610 Therapy for immunosuppression |
| 09/30/1997 | US5672609 Pyridine compounds, intermediates compositions and methods of use |
| 09/30/1997 | US5672608 Acenaphthyl substituted guanidines and methods of use thereof |
| 09/30/1997 | US5672607 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 09/30/1997 | US5672605 Macrolide immunomodulators |
| 09/30/1997 | US5672603 Apoptosis regulating composition |
| 09/30/1997 | US5672602 Substituted piperazine derivatives |
| 09/30/1997 | US5672600 Antimicrobial dithiocarbamoyl quinolones |
| 09/30/1997 | US5672599 Compounds containing a fused bicycle ring |
| 09/30/1997 | US5672598 Matrix metalloprotease inhibitors |
| 09/30/1997 | US5672596 Animal growth controllers |
| 09/30/1997 | US5672595 Method of controlling male fertility |
| 09/30/1997 | US5672594 Anticarcinogenic,-tumor and -parasitic agents; viricides; fungicides; bactericides; hiv virus |
| 09/30/1997 | US5672593 Anticancer agents |
| 09/30/1997 | US5672590 Consists of d-ribose, 2-deoxy-d-ribose, alpha-alanine, nicotinic acid and l-ascorbic acid; stimulating the production of cytokines |
| 09/30/1997 | US5672589 Crystalline lactitol monohydrate and a process for the preparation thereof, use thereof, and sweetening agent |
| 09/30/1997 | US5672587 Isoproterenol prodrug with reduced side effects |
| 09/30/1997 | US5672586 Herpes ribonucleotide reductase inhibitors |
| 09/30/1997 | US5672583 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 09/30/1997 | US5672582 Anticoagulants; 4-substituted cyclohexylamine derivatives |
| 09/30/1997 | US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins |
| 09/30/1997 | US5672492 Fungicidally active compounds |
| 09/30/1997 | US5672361 Laminin 5 for growth of pancreatic islet cells |
| 09/30/1997 | US5672360 24-hour sustained release dosage of morphine or morphine sulfate |
| 09/30/1997 | US5672358 Controlled release aqueous emulsion |
| 09/30/1997 | US5672355 Injection of liquid silicone/fluorosilicone copolymer oil for repairing detached retina or drug delivery during eye surgery |
| 09/30/1997 | US5672338 Hair conditioners/sprays |
| 09/30/1997 | US5672335 Administering to enhance contrast in computer tomography |
| 09/30/1997 | CA2129676C Dextromethorphan antitussive compositions |
| 09/30/1997 | CA2091686C Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anesthesia of eyes, based thereon |
| 09/30/1997 | CA2055463C Antiviral therapy using thiazine and xanthene dyes |
| 09/30/1997 | CA1339481C Anthelmintic bioconversion products |
| 09/30/1997 | CA1339480C Antiparasitic agents and process for their preparation |
| 09/29/1997 | CA2200267A1 Novel sphingolipids and a process thereto |
| 09/27/1997 | CA2201089A1 Use of .alpha.1 -adrenoreceptor antagonists in the prevention and treatment of cancer |
| 09/27/1997 | CA2201088A1 Use of .alpha.1 -adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
| 09/27/1997 | CA2201040A1 Solid pharmaceutical preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide |
| 09/27/1997 | CA2172641A1 Method and composition for treatment of impaired glucose tolerance |
| 09/27/1997 | CA2172640A1 Method and composition for treatment of impaired glucose tolerance by the use of chromic picolinate |
| 09/25/1997 | WO1997035193A1 Cryptic peptides and method for their identification |
| 09/25/1997 | WO1997035024A1 Enzyme combinations for destroying proliferative cells |
| 09/25/1997 | WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells |
| 09/25/1997 | WO1997035015A2 Tyrosine-phosphatase-related protein |
| 09/25/1997 | WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a) |
| 09/25/1997 | WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997035005A2 Cftr gene regulator |
| 09/25/1997 | WO1997035002A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | WO1997034930A1 Stable factor viii/ von willebrand factor complex |
| 09/25/1997 | WO1997034929A1 Process for extraction of a growth factor complex |
| 09/25/1997 | WO1997034927A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/25/1997 | WO1997034924A1 Process and intermediates for the synthesis of lhrh antagonists |
| 09/25/1997 | WO1997034923A1 Process and intermediates for the synthesis of lhrh antagonists |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034904A1 Siloxane dyes, compositions containing same and uses thereof |
| 09/25/1997 | WO1997034901A1 Piperidine derivatives |
| 09/25/1997 | WO1997034900A1 Azaspiro derivatives |
| 09/25/1997 | WO1997034899A1 Heterocyclic compounds and their preparation and use |
| 09/25/1997 | WO1997034897A1 Fused imidazole derivatives as multidrug resistance modulators |
| 09/25/1997 | WO1997034895A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use |
| 09/25/1997 | WO1997034894A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 09/25/1997 | WO1997034893A1 Pharmaceutically useful compounds |
| 09/25/1997 | WO1997034887A1 NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS |
| 09/25/1997 | WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 09/25/1997 | WO1997034884A1 Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 09/25/1997 | WO1997034883A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 09/25/1997 | WO1997034882A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
| 09/25/1997 | WO1997034878A1 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 09/25/1997 | WO1997034876A1 Cinnoline derivatives and use as medicine |
| 09/25/1997 | WO1997034874A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action |